A Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1165 participants.

Also called NCT06825416

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 1,165 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06825416
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06825416. Randomized; quadruple masking; primary purpose prevention. Start 2025-03-16 (actual); primary completion 2026-02-15 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty
Condition
Prevention of Arterial and Venous Thrombosis
Intervention (Drug)
SHR-2004 injection
Intervention (Drug)
SHR-2004 injection
Intervention (Drug)
Enoxaparin sodium injection
Intervention (Drug)
Enoxaparin sodium injection placebo
Intervention (Drug)
SHR-2004 placebo
Intervention (Drug)
SHR-2004 placebo
Lead sponsor
Beijing Suncadia Pharmaceuticals Co., Ltd (class: industry)

Record details

Record id
cardio:ct-nct06825416
Content hash
13d0c3c91eaf83cd9260839ff5818c23a280791eb27a64ccd23fc705b136ee64